Canhua Xu

Mr. Canhua Xu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HGHou-Yun Gu
Hou-Yun Gu
FLFei-Xiang Lin
Fei-Xiang Lin
NLNing Liu
Ning Liu
CXCanhua Xu
Canhua Xu
Traumatic spinal cord injury (tSCI) is a severe disabling central nervous system injury caused by external forces directly acting on the spinal cord. It can rapidly trigger the release of a large number of pro-inflammatory mediators after the injury, leading to significant neurological dysfunction and, in severe cases, paralysis. Currently, symptoms are mainly alleviated, and endogenous repair mechanisms are improved through drug intervention, surgery, stem cell transplantation, behavioral interventions, physical stimulation, and supportive therapies. However, these methods do not directly promote nerve regeneration and functional recovery. The inflammatory response after injury is an important pathological process leading to secondary damage and plays a crucial role in regulating the pathological progression of acute and chronic tSCI. However, prolonged inflammatory stimulation can further worsen the microenvironment at the injury site, leading to neurological function decline. Therefore, regulating the inflammatory microenvironment and restoring cytokine balance are expected to promote the recovery of neurological function after injury. This review summarizes the formation of the inflammatory microenvironment after tSCI, focusing on the recruitment and activation characteristics of major inflammation-related cells, and elaborates on the expression regulation, pathological effects, and impacts of key cytokines—including the interleukin family, TNF-α, and various chemokines—on neuronal survival and axonal regeneration. Additionally, we summarize multiple inflammatory signaling pathways closely related to secondary injury, such as NF-κB, JAK/STAT, and MAPK, emphasizing that these pathways are interconnected. For example, TNF-α and IL-1β can jointly activate NF-κB and MAPK to amplify the pro-inflammatory response and disrupt the blood-spinal cord barrier. Meanwhile, JAK-STAT3 amplifies inflammation while driving reactive proliferation of astrocytes and glial scar formation, thereby limiting later axonal regeneration. Based on this mutually amplifying inflammatory network, we also briefly summarize the exploratory applications of chemical antagonists, biologic agents, neuroprotective molecules, plant-derived active compounds, and hormonal interventions in regulating this microenvironment. This article aims to provide a reference for the analysis of inflammation-mediated pathological mechanisms after tSCI and the development of targeted anti-inflammatory treatment strategies.

14 July 2026 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
PMPingfan Mo
Pingfan Mo
RCRongchun Chen
Rongchun Chen
LSLinbo Sun
Linbo Sun
YCYunsheng Chen
Yunsheng Chen
JXJun Xiong
Jun Xiong
CXCanhua Xu
Canhua Xu